{"id":"W1506042288","doi":"10.1002/pbc.25133","title":"Efficacy of CPX‐351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program","year":2014,"lang":"en","type":"article","venue":"Pediatric Blood & Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"National Cancer Institute; Celator Pharmaceuticals; University of New South Wales","keywords":"Daunorubicin; Cytarabine; Medicine; Pharmacology; Cmax; Pharmacokinetics; Leukemia; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009715314,0.0006192568,0.001282048,0.000572274,0.000197293,0.00003958602,0.0009117336,0.0004960349,0.00005070786],"category_scores_gemma":[0.002842037,0.0004527706,0.0005539731,0.003507801,0.0004000471,0.0002437527,0.000528919,0.0009261173,0.00002240786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007608547,"about_ca_system_score_gemma":0.004764604,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008137119,"about_ca_topic_score_gemma":0.0000305183,"domain_scores_codex":[0.9939157,0.0003123574,0.001844462,0.00100363,0.001767421,0.001156422],"domain_scores_gemma":[0.9935272,0.002357571,0.001110778,0.001320998,0.001161607,0.0005217866],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002548931,0.004584647,0.8970702,0.004786537,0.002014045,0.0000553319,0.001093118,0.04238553,0.004515462,0.0001494595,0.004551864,0.03624489],"study_design_scores_gemma":[0.08766989,0.01500704,0.4957219,0.001549263,0.04455406,0.0008495321,0.0001595543,0.3395924,0.00920461,0.0009682688,0.001471843,0.003251615],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930526,0.001953024,0.0004601712,0.0002628422,0.000707582,0.002182739,0.00007384906,0.0002655076,0.001041696],"genre_scores_gemma":[0.9900358,0.002149336,0.002937222,0.0003077401,0.003703262,0.0003736804,0.00002516438,0.0001506595,0.0003171597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4013483,"threshold_uncertainty_score":0.9997924,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02999631826602936,"score_gpt":0.313768197906212,"score_spread":0.2837718796401826,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}